On Friday, Zymeworks BC Inc (NASDAQ: ZYME) was -8.04% drop from the session before settling in for the closing price of $17.9. A 52-week range for ZYME has been $9.03 – $19.98.
Healthcare Sector giant saw their annual sales surged by 15.81% over the last five years. When this article was written, the company’s average yearly earnings per share was at 45.02%. With a float of $72.81 million, this company’s outstanding shares have now reached $75.14 million.
Zymeworks BC Inc (ZYME) Breakdown of a Key Holders of the stock
Also, it is sometimes useful to examine the sentiment of large-scale investors toward Zymeworks BC Inc stocks. The insider ownership of Zymeworks BC Inc is 3.44%, while institutional ownership is 98.49%. The most recent insider transaction that took place on May 15 ’25, was worth 565,847. In this transaction Director of this company bought 49,502 shares at a rate of $11.43, taking the stock ownership to the 17,877,989 shares. Before that another transaction happened on May 19 ’25, when Company’s Director bought 5,919 for $11.78, making the entire transaction worth $69,738. This insider now owns 17,883,908 shares in total.
Zymeworks BC Inc (ZYME) Recent Fiscal highlights
Going through the last 3-months fiscal report unveiled on the 12/31/2024, it has been observed that the corporation posted -0.31 earnings per share (EPS) during the time that was less than consensus figure (set at -0.09) by -0.22. Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.14 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 45.02% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 10.91% during the next five years compared to 15.81% growth over the previous five years of trading.
Zymeworks BC Inc (NASDAQ: ZYME) Trading Performance Indicators
You can see what Zymeworks BC Inc (ZYME) is doing with its current performance indicators. In the most recent quarter, the stock posted a quick ratio of 6.94. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 9.23.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.85, a number that is poised to hit -0.53 in the next quarter and is forecasted to reach -0.67 in one year’s time.
Technical Analysis of Zymeworks BC Inc (ZYME)
Analysing the last 5-days average volume posted by the [Zymeworks BC Inc, ZYME], we can find that recorded value of 0.88 million was better than the volume posted last year of 0.58 million. As of the previous 9 days, the stock’s Stochastic %D was 18.05%.
During the past 100 days, Zymeworks BC Inc’s (ZYME) raw stochastic average was set at 58.44%, which indicates a significant increase from 11.48% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 0.76 in the past 14 days, which was higher than the 0.63 volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $16.96, while its 200-day Moving Average is $13.88. Now, the first resistance to watch is $17.12. This is followed by the second major resistance level at $17.78. The third major resistance level sits at $18.34. If the price goes on to break the first support level at $15.90, it is likely to go to the next support level at $15.34. Now, if the price goes above the second support level, the third support stands at $14.69.
Zymeworks BC Inc (NASDAQ: ZYME) Key Stats
There are 75,166K outstanding shares of the company, which has a market capitalization of 1.24 billion. As of now, sales total 76,300 K while income totals -122,700 K. Its latest quarter income was 48,730 K while its last quarter net income were 2,320 K.
